Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Preferred stock Series X redeemable convertible preferred stock	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss	Total
Beginning balance at Dec. 31, 2020	$ 0	$ 4	$ 301,562	$ (260,897)	$ 0	$ 40,669
Beginning balance (in shares) at Dec. 31, 2020	0	3,347,386
Increase (Decrease) in Shareholders' Equity
Issuance of preferred stock in a private offering of public equity, net of issuance costs			19,565			19,565
Issuance of preferred stock and common stock upon acquisition of Quellis			8,098			8,098
Issuance of preferred stock and common stock upon acquisition of Quellis(in shares)		555,444
Expense related to warrants inherited in acquisition of Quellis			241			241
Stock-based compensation expense			366			366
Net loss				(170,084)		(170,084)
Ending balance at Mar. 31, 2021		$ 4	329,832	(430,981)		(101,145)
Ending balance (in shares) at Mar. 31, 2021		3,902,830
Beginning balance at Dec. 31, 2020	$ 0	$ 4	301,562	(260,897)	0	40,669
Beginning balance (in shares) at Dec. 31, 2020	0	3,347,386
Increase (Decrease) in Shareholders' Equity
Net loss						(177,550)
Ending balance at Jun. 30, 2021	$ 99,770	$ 13	475,563	(438,447)	0	136,899
Ending balance (in shares) at Jun. 30, 2021	32,545	12,824,796
Beginning balance at Mar. 31, 2021		$ 4	329,832	(430,981)		(101,145)
Beginning balance (in shares) at Mar. 31, 2021		3,902,830
Increase (Decrease) in Shareholders' Equity
Reclassification of preferred stock to permanent equity	$ 240,881					240,881
Reclassification of preferred stock to permanent equity (in shares)	86,077
Issuance of common stock upon the conversion of preferred stock	$ (165,548)	$ 9	165,540			1
Issuance of common stock upon the conversion of preferred stock (in shares)	(53,532)	8,921,966
Accretion of preferred stock discount	$ 24,437		(24,437)
Expense related to warrants inherited in acquisition of Quellis			146			146
Reclassification of equity classified warrants			3,468			3,468
Stock-based compensation expense			1,014			1,014
Net loss				(7,466)		(7,466)
Ending balance at Jun. 30, 2021	$ 99,770	$ 13	475,563	(438,447)	0	136,899
Ending balance (in shares) at Jun. 30, 2021	32,545	12,824,796
Beginning balance at Dec. 31, 2021	$ 96,398	$ 13	481,709	(455,809)	0	122,311
Beginning balance (in shares) at Dec. 31, 2021	31,455	13,016,955
Increase (Decrease) in Shareholders' Equity
Expense related to warrants inherited in acquisition of Quellis			1,542			1,542
Stock-based compensation expense			1,209			1,209
Net loss				(15,324)		(15,324)
Unrealized loss on short-term investments					(53)	(53)
Ending balance at Mar. 31, 2022	$ 96,398	$ 13	484,460	(471,133)	(53)	109,685
Ending balance (in shares) at Mar. 31, 2022	31,455	13,016,955
Beginning balance at Dec. 31, 2021	$ 96,398	$ 13	481,709	(455,809)	0	122,311
Beginning balance (in shares) at Dec. 31, 2021	31,455	13,016,955
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon the conversion of preferred stock (in shares)		9,103,664
Net loss						(26,574)
Realized loss on short-term investments						(186)
Ending balance at Jun. 30, 2022	$ 96,398	$ 13	485,577	(482,383)	(186)	99,419
Ending balance (in shares) at Jun. 30, 2022	31,455	13,016,955
Beginning balance at Mar. 31, 2022	$ 96,398	$ 13	484,460	(471,133)	(53)	109,685
Beginning balance (in shares) at Mar. 31, 2022	31,455	13,016,955
Increase (Decrease) in Shareholders' Equity
Stock-based compensation expense			1,117			1,117
Net loss				(11,250)		(11,250)
Unrealized loss on short-term investments					(133)	(133)
Realized loss on short-term investments						(133)
Ending balance at Jun. 30, 2022	$ 96,398	$ 13	$ 485,577	$ (482,383)	$ (186)	$ 99,419
Ending balance (in shares) at Jun. 30, 2022	31,455	13,016,955